Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A cirrhotic ascites and drug technology, applied in the field of medicine, can solve the problems of water and electrolyte disorders, long-term use, slow curative effect of traditional Chinese medicine, etc., and achieve the effect of relieving pain, improving liver function, and quick results
Inactive Publication Date: 2017-06-16
HENAN SHUIJINGTOU CULTURAL MEDIA CO LTD
View PDF0 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Western medicine eliminates ascites quickly, focusing on improving liver function, using diuretics to increase the excretion of water and sodium, and promoting the resolution of ascites, but it is easy to cause water and electrolyte disorders
The curative effect of traditional Chinese medicine is slow, and it needs to be used for a long time
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0016] In an embodiment of the present invention, a medicine for treating liver cirrhosis ascites is composed of the following raw materials in parts by weight: 7 parts of rutin, 1 part of benzbromarone, 11 parts of glycerin, and 3 parts of naringin.
[0017] Mix and grind benzbromarone and glycerol, pass through a 120-mesh sieve, add deionized water 3.7 times the mass of the two, then raise the temperature to 81°C, and stir at this temperature for 36 minutes to prepare mixture A. Put naringin and rutin into the mixture A, then ultrasonically treat at 56°C for 28 minutes with an ultrasonic power of 1000W, then stir at 61°C until dry, and granulate to obtain the drug.
Embodiment 2
[0019] In an embodiment of the present invention, a medicine for treating liver cirrhosis ascites is composed of the following raw materials in parts by weight: 15 parts of rutin, 5 parts of benzbromarone, 19 parts of glycerin, and 7 parts of naringin.
[0020] Mix and grind benzbromarone and glycerol, pass through a 120-mesh sieve, add deionized water 3.7 times the mass of the two, then raise the temperature to 83°C, and stir at this temperature for 39 minutes to prepare mixture A. Put naringin and rutin into the mixture A, then ultrasonically treat at 56°C for 28 minutes with an ultrasonic power of 1000W, then stir at 61°C until dry, and granulate to obtain the drug.
Embodiment 3
[0022] In an embodiment of the present invention, a medicine for treating liver cirrhosis ascites is composed of the following raw materials in parts by weight: 9 parts of rutin, 2 parts of benzbromarone, 13 parts of glycerin, and 4 parts of naringin.
[0023] Mix and grind benzbromarone and glycerol, pass through a 120-mesh sieve, add deionized water 3.7 times the mass of the two, then raise the temperature to 82°C, and stir at this temperature for 37 minutes to prepare mixture A. Put naringin and rutin into the mixture A, then ultrasonically treat at 56°C for 28 minutes with an ultrasonic power of 1000W, then stir at 61°C until dry, and granulate to obtain the drug.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a cirrhosis ascites treatment medicine. The medicine comprises, by weight, 7-15 parts of rutin, 1-5 parts of benzbromarone, 11-19 parts of glycerol and 3-7 parts of naringin. The medicine is prepared through the following steps: mixing and grinding the benzbromarone and the glycerol, sieving the obtained mixture by a 120 mesh sieve, adding deionized water with the mass 3.7 times the total mass of the benzbromarone and the glycerol, heating the obtained solution to 81-83 DEG C, and stirring the solution at 81-83 DEG C for 36-39 min to prepare a mixture A; and adding naringin and rutin to the mixture A, carrying out ultrasonic treatment at 56 DEG C for 28 min, stirring the obtained mixture at 61 DEG C until the mixture is dry, and granulating the dry mixture. The total effective treatment rate of cirrhosis ascites reaches 98% or above, and the medicine improves the liver functions of patients, corrects hypoproteinemia, rapidly eliminates ascites, and reduces complications. The cirrhosis ascites treatment medicine has the advantages of simple and easily available raw materials, simple preparation technology, low production cost, good curative effect, fast effect, no toxic or side effects, and suitableness for large-scale production and promotion.
Description
technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating liver cirrhosis ascites. Background technique [0002] Liver cirrhosis is a common clinical chronic progressive liver disease, which is diffuse liver damage caused by long-term or repeated effects of one or more causes. In my country, most of them are post-hepatitis cirrhosis, and a small part are alcoholic cirrhosis and schistosome cirrhosis. Histopathologically, extensive liver cell necrosis, nodular regeneration of residual liver cells, connective tissue hyperplasia, and fibrous septum formation lead to structural destruction of hepatic lobules and formation of pseudolobules. The liver gradually deforms and hardens and develops into cirrhosis. In the early stage, there are no obvious symptoms due to the strong compensatory function of the liver. In the later stage, liver function damage and portal hypertension are the main manifestations, and multiple...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more